Longitudinal Study of Local Ablative Therapy in Oligometastatic Disease

NARecruitingINTERVENTIONAL
Enrollment

1,200

Participants

Timeline

Start Date

April 15, 2024

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2035

Conditions
Oligometastatic DiseaseMetastasesAblation TechniquesRadiotherapyStereotactic RadiationSurgery
Interventions
PROCEDURE

Local ablative therapy (LAT)

Surgical metastasectomy, stereotactic ablative radiotherapy, thermal ablation, or electroporation to all oligometastatic lesions

Trial Locations (11)

2100

NOT_YET_RECRUITING

Copenhagen University Hospital Rigshospitalet, Copenhagen

2730

RECRUITING

Copenhagen University Hospital Herlev and Gentofte, Herlev

3400

NOT_YET_RECRUITING

Hillerød Hospital, Hillerød

4000

NOT_YET_RECRUITING

Zealand University Hospital, Roskilde and Næstved, Roskilde

5000

NOT_YET_RECRUITING

Odense University Hospital, Odense

6400

NOT_YET_RECRUITING

Sønderborg Hospital, Sønderborg

7100

NOT_YET_RECRUITING

Vejle Hospital, Vejle

7400

NOT_YET_RECRUITING

Gødstrup Hospital, Herning

8200

NOT_YET_RECRUITING

Aarhus University Hospital, Aarhus

NOT_YET_RECRUITING

Danish Center for Particle Therapy, Aarhus

9000

NOT_YET_RECRUITING

Aalborg University Hospital, Aalborg

All Listed Sponsors
lead

Gitte Fredberg Persson MD PhD

OTHER